Barings Portfolio holdings
Barings is a subsidiary of the insurer MassMutual that invests in fixed income, stocks, real estate and alternative assets. Its core began as David L. Babson & Company, founded in 1940 and bought by MassMutual in 1995. Baring Asset Management, which traces back to a merchant bank the Baring brothers founded in London in 1762, was bought by MassMutual in 2004 and became a Babson subsidiary in 2016. Babson, by then Babson Capital Management, took the Barings name in September 2016, and MassMutual's real estate adviser merged into the firm that December. Its clients include pension plans, endowments, foundations, banks and insurance companies, as well as MassMutual itself.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$13.9M |
| 2 |
Johnson & Johnson
JNJ
|
+$7.58M |
| 3 |
Microsoft
MSFT
|
+$5.92M |
| 4 |
UnitedHealth
UNH
|
+$5.04M |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
|
+$14.9M |
| 2 |
J.M. Smucker
SJM
|
+$10.6M |
| 3 |
Amazon
AMZN
|
+$8.88M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$6.69M |
| 5 |
PepsiCo
PEP
|
+$6.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.49% |
| 2 | Technology | 7.26% |
| 3 | Industrials | 6.97% |
| 4 | Financials | 6.04% |
| 5 | Consumer Discretionary | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$803B
| $899M | 23.98% |
4,376,000
-1,150,000
| -21% | -$224M |
2013 Q4
9 quarters
|
|
2
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.3B
| $340M | 9.05% |
9,915,000
-1,674,200
| -14% | -$51.9M |
2013 Q4
9 quarters
|
|
3
PUT
iShares MSCI EAFE ETF
EFA
$77.2B
| $211M | 5.63% |
3,692,000
+20,000
| +0.5% | +$1.1M |
2013 Q4
9 quarters
|
|
4
PUT
iShares Russell 2000 ETF
IWM
$77.3B
| $92.9M | 2.48% |
840,000
+170,000
| +25% | +$17.6M |
2014 Q3
6 quarters
|
|
5
iShares Russell 3000 ETF
IWV
$20.3B
| $58.8M | 1.57% |
486,189
| – | – |
2013 Q2
11 quarters
|
|
6
Apple
AAPL
$5.16T
| $46.8M | 1.25% |
1,717,424
-243,640
| -12% | -$6.07M |
2013 Q2
11 quarters
|
|
|
7
Microsoft
MSFT
$3.88T
| $32.7M | 0.87% |
592,696
+113,000
| +24% | +$5.92M |
2013 Q2
11 quarters
|
|
|
8
Johnson & Johnson
JNJ
$683B
| $29.2M | 0.78% |
270,311
+73,250
| +37% | +$7.58M |
2013 Q2
11 quarters
|
|
9
GE Aerospace
GE
$343B
| $28.4M | 0.76% |
186,557
+7,742
| +4% | +$1.09M |
2013 Q2
11 quarters
|
|
10
BlackRock TCP Capital
TCPC
$345M
| $23.9M | 0.64% |
1,603,372
| – | – |
2013 Q2
11 quarters
|
|
11
Verizon
VZ
$193B
| $20.1M | 0.54% |
371,387
-11,700
| -3% | -$585K |
2013 Q2
11 quarters
|
|
12
ExxonMobil
XOM
$693B
| $19.2M | 0.51% |
229,736
+13,600
| +6% | +$1.09M |
2013 Q2
11 quarters
|
|
13
Gilead Sciences
GILD
$208B
| $18.3M | 0.49% |
199,722
-2,100
| -1% | -$189K |
2013 Q2
11 quarters
|
|
14
Alphabet (Google) Class A
GOOGL
$3.67T
| $16.6M | 0.44% |
434,460
| – | – |
2015 Q4
1 quarter
|
|
15
Home Depot
HD
$347B
| $15.5M | 0.41% |
116,147
+8,960
| +8% | +$1.12M |
2013 Q2
11 quarters
|
|
|
16
Meta Platforms (Facebook)
META
$1.59T
| $15.3M | 0.41% |
134,260
+47,120
| +54% | +$4.97M |
2013 Q3
10 quarters
|
|
17
Citigroup
C
$205B
| $14.7M | 0.39% |
352,121
+4,100
| +1% | +$171K |
2013 Q2
11 quarters
|
|
|
18
UnitedHealth
UNH
$363B
| $13.8M | 0.37% |
106,835
+42,600
| +66% | +$5.04M |
2013 Q2
11 quarters
|
|
19
Alphabet (Google) Class C
GOOG
$3.63T
| $13.4M | 0.36% |
358,520
-33,600
| -9% | -$1.2M |
2013 Q2
11 quarters
|
|
|
AGN.PRA
20
DELISTED
Allergan plc
AGN.PRA
| $13.3M | 0.35% |
+14,500
| New | +$13.9M |
2016 Q1
0 quarters
|
|
21
Wells Fargo
WFC
$257B
| $13.1M | 0.35% |
271,090
-7,000
| -3% | -$343K |
2013 Q2
11 quarters
|
|
22
JPMorgan Chase
JPM
$910B
| $12.9M | 0.34% |
217,014
-92,100
| -30% | -$5.38M |
2013 Q2
11 quarters
|
|
|
AEUA
23
DELISTED
Anadarko Petroleum Corporation
AEUA
| $12.4M | 0.33% |
360,000
| – | – |
2015 Q2
3 quarters
|
|
24
Amgen
AMGN
$253B
| $12.3M | 0.33% |
82,296
-9,050
| -10% | -$1.34M |
2013 Q2
11 quarters
|
|
25
Oracle
ORCL
$396B
| $12.2M | 0.33% |
297,945
+98,600
| +49% | +$3.65M |
2013 Q2
11 quarters
|
|
Similar funds
Barings's Q1 2016 Portfolio in Review
As of Q1 2016, Barings held 1,030 positions worth $3.75B, down 6.2% from $4B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barings deployed $217M of net new capital in Q1 2016, opening 125 new positions and adding to 236 existing holdings. Its largest new stake was Allergan plc: 14,500 shares worth $13.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 54% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was J.M. Smucker, an estimated $10.6M trimmed.
- Barings's largest Q1 2016 buy was Allergan plc: 14,500 shares worth $13.3M.
- Barings added most to Johnson & Johnson in Q1 2016, an estimated $7.58M increase.
- Barings's biggest Q1 2016 reduction was J.M. Smucker, cutting an estimated $10.6M.
- Barings fully exited ACTAVIS PLC Pfd Conv Ser A (Irl) in Q1 2016, selling an estimated $14.9M.
- Barings's ten largest holdings make up 47% of its $3.75B portfolio in Q1 2016.
- Barings opened 125 new positions and closed 95 in Q1 2016.
- Barings's portfolio value fell 6.2% quarter-over-quarter to $3.75B.
Based on Barings's 13F filing for Q1 2016, filed 16 May 2016.